GlassScriptPhysician profile
John P Guste
NPI 1710121306
$10,188.39
in general payments reported to CMS, 2019-2025
18 companies · $3,360 in 2025
The $3,360 reported for 2025 was more than what 89% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,356 · 2020: $707 · 2021: $728 · 2022: $1,138 · 2023: $1,496 · 2024: $1,403 · 2025: $3,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,804 · Travel and Lodging: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,803.97 |
| Travel and Lodging | $1,455.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,801.26 | 2023-2025 | |
| Axogen | $2,524.81 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Allergan, INC. | $1,982.27 | 2019-2022 | |
| Mentor Worldwide LLC | $1,491.09 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Davol INC. | $244.95 | 2019-2022 | |
| Galderma Laboratories, L.P. | $215.35 | 2019-2022 | |
| Baxter Healthcare | $176.87 | 2019-2020 | |
| Stryker Corporation | $164.45 | 2022-2025 | Spy-Phi System |
| Integra Lifesciences Corporation | $149.30 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $113.45 | 2024 | Novosorb Btm |
| Organogenesis INC. | $95.24 | 2025 | Puraply Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $54.68 | 2025 | |
| Sientra, INC. | $39.71 | 2019-2020 | |
| Kci USA, INC. | $34.71 | 2019 | |
| Covidien LP | $32.48 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $28.61 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.17 | 2020 | |
| Tela Bio, INC. | $18.99 | 2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Guste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.